
A newly identified mutation dramatically raises prostate cancer risk in Ashkenazi Jewish men and may increase sensitivity to targeted cancer therapies. This genetic clue not only improves our understanding of inherited cancer risks but could also inform personalized treatment strategies using drugs like PARP inhibitors. A Breakthrough Discovery in Prostate Cancer Genetics Understanding gene mutations, [...]